Cytosorbents (CTSO)
(Delayed Data from NSDQ)
$0.89 USD
0.00 (0.24%)
Updated Jun 7, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Cytosorbents Corporation [CTSO]
Reports for Purchase
Showing records 101 - 120 ( 184 total )
Company: Cytosorbents Corporation
Industry: Medical - Products
Company: Cytosorbents Corporation
Industry: Medical - Products
Company: Cytosorbents Corporation
Industry: Medical - Products
Margin Growth to Drive Operational Profitability; Pivotal Studies Initiating; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Cytosorbents Corporation
Industry: Medical - Products
Company: Cytosorbents Corporation
Industry: Medical - Products
Starting 2018 on a High; Raising PT to $14; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Cytosorbents Corporation
Industry: Medical - Products
Company: Cytosorbents Corporation
Industry: Medical - Products
Revenues Hitting New Highs on Strong Execution; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Cytosorbents Corporation
Industry: Medical - Products
Company: Cytosorbents Corporation
Industry: Medical - Products
SMALL-CAP SQUAWK
Provider: JGR Capital Partners
Company: Cytosorbents Corporation
Industry: Medical - Products
Company: Cytosorbents Corporation
Industry: Medical - Products
Positive Sepsis Results Highlight CytoSorb Potential; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Cytosorbents Corporation
Industry: Medical - Products
Company: Cytosorbents Corporation
Industry: Medical - Products
Strong German Market Driving Revenue Growth; Looking to REFRESH II; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Cytosorbents Corporation
Industry: Medical - Products
Company: Cytosorbents Corporation
Industry: Medical - Products
Company: Cytosorbents Corporation
Industry: Medical - Products
REFRESH I Results Shed Light on Cytosorb Potential; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Cytosorbents Corporation
Industry: Medical - Products
Company: Cytosorbents Corporation
Industry: Medical - Products
Company: Cytosorbents Corporation
Industry: Medical - Products
At an Inflection Point; Raising PT to $13.00; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Cytosorbents Corporation
Industry: Medical - Products
Expanded Fresenius Partnership to Bolster 2017; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S